April 30, 2021
Pfizer Japan said on April 28 that its revenue in FY2020 (December 2019-November 2020) checked in at 251 billion yen, versus 458.6 billion yen in FY2019, following the spinoff of its Upjohn off-patent drug business in November last year. The...read more